With ITG's Storyteq technology having been named a Leader in the Gartner® Magic Quadrant™ for both Content Marketing Platforms and Digital Asset Management, David Mackay's appointment capitalizes on the company's momentum to bring ITG's AI-enabled content solutions to more US marketers. Inspired Thinking Group (ITG), the tech-enabled, agile content business, has today announced the appointment […]

Pomerantz LLP is investigating claims on behalf of investors of AstraZeneca PLC (“AstraZeneca” or the “Company”)(NASDAQ: AZN).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether AstraZeneca and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information

(NYSE:BDN), PHILADELPHIA, Jan. 21, 2025 (GLOBE NEWSWIRE) — Brandywine Realty Trust (NYSE: BDN) today announced strong leasing activity across its portfolio, reflecting sustained demand for high-quality office, and mixed-use spaces. Since last quarter and through today, the Company has executed 650,000 square feet of leasing activity throughout its portfolio, underscoring the strength of Brandywine's core

https://mma.prnewswire.com/media/2598307/32a64817_10ba_407b_947c_76bd790799f6_Logo.jpg Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sun Communities, Inc. (NYSE: SUI) between February 28, 2019 and September 24, 2024, both dates inclusive (the “Class Period”), of the importantFebruary 10, 2025 lead plaintiff deadline. So what: If you purchased Sun Communities securities during the Class Period

NEW YORK, NY / ACCESS Newswire / January 21, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Keros Therapeutics, Inc. ("Keros Therapeutics, Inc.") (NASDAQ:KROS) concerning possible violations of federal securities laws. Keros issued a press release on December 12, 2024, "announc[ing] that it has voluntarily halted dosing in the

NEW YORK, NY / ACCESS Newswire / January 21, 2025 / If you suffered a loss on your Symbotic Inc. (NASDAQ:SYM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/symbotic-lawsuit-submission-form-2?prid=124193&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

NEW YORK, NY / ACCESS Newswire / January 21, 2025 / If you suffered a loss on your Micron Technology, Inc. (NASDAQ:MU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/micron-technology-inc-lawsuit-submission-form?prid=124192&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK, NY / ACCESS Newswire / January 21, 2025 / If you suffered a loss on your FTAI Aviation Ltd. (NASDAQ:FTAI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ftai-aviation-ltd-lawsuit-submission-form?prid=124190&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK, NY / ACCESS Newswire / January 21, 2025 / If you suffered a loss on your Celsius Holdings, Inc. (NASDAQ:CELH) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/celsius-holdings-inc-lawsuit-submission-form?prid=124198&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK, NY / ACCESS Newswire / January 21, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Red Cat Holdings, Inc. ("Red Cat Holdings, Inc.") (NASDAQ:RCAT) concerning possible violations of federal securities laws. Red Cat Holdings, Inc. is the subject of a report released by Kerrisdale Capital. Kerrisdale Capital